Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 17/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807125 | 0.89 | PLA2G4A (0.57) | PLA2G4AMAPTPOLB | |
| SCHEMBL2804337 | 0.88 | PLA2G4A (0.58) | PLA2G4AMAPTPOLB | |
| SCHEMBL2810890 | 0.85 | PLA2G4A (0.80) | PLA2G4A | |
| SCHEMBL3920399 | 0.84 | PLA2G4A (0.58) | PLA2G4AS1PR1 | |
| SCHEMBL3931705 | 0.82 | PLA2G4A (0.58) | PLA2G4AMAPTPOLBS1PR1TP53 | |
| SCHEMBL3926819 | 0.80 | PLA2G4A (0.57) | PLA2G4AS1PR1 | |
| SCHEMBL2806320 | 0.80 | PLA2G4A (0.52) | PLA2G4AMAPTTP53THRB | |
| SCHEMBL2806823 | 0.79 | PLA2G4A (0.54) | PLA2G4A | |
| SCHEMBL3920460 | 0.78 | PLA2G4A (0.59) | PLA2G4AS1PR1 | |
| SCHEMBL3924250 | 0.75 | CNR2 (0.46) | PLA2G4AS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | WESTFALISCHE WILHELMS UNIVERSITÄT MÜNSTER (DE) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | PLD2, PLA2G1B, PLA2G4A | PLA2G4A 3/4885MAPT 4523/4885POLB 3188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.